Merck Total Long-Term Assets 2010-2024 | MKKGY

Merck total long-term assets from 2010 to 2024. Total long-term assets can be defined as the sum of all assets classified as non-current
  • Merck total long-term assets for the quarter ending June 30, 2024 were $39.661B, a 1.71% increase year-over-year.
  • Merck total long-term assets for 2023 were $39.073B, a 2.09% increase from 2022.
  • Merck total long-term assets for 2022 were $38.273B, a 5.9% decline from 2021.
  • Merck total long-term assets for 2021 were $40.674B, a 9.51% increase from 2020.
Merck Annual Total Long-Term Assets
(Millions of US $)
2023 $39,073
2022 $38,273
2021 $40,674
2020 $37,143
2019 $38,984
2018 $32,656
2017 $31,836
2016 $33,841
2015 $34,020
2014 $20,644
2013 $17,845
2012 $19,314
2011 $21,902
2010 $
2009 $
Merck Quarterly Total Long-Term Assets
(Millions of US $)
2024-06-30 $39,661
2024-03-31 $39,825
2023-12-31 $39,073
2023-09-30 $39,550
2023-06-30 $38,995
2023-03-31 $38,306
2022-12-31 $38,273
2022-09-30 $38,264
2022-06-30 $38,632
2022-03-31 $39,445
2021-12-31 $40,674
2021-09-30 $39,529
2021-06-30 $39,717
2021-03-31 $40,115
2020-12-31 $37,143
2020-09-30 $38,543
2020-06-30 $37,542
2020-03-31 $38,314
2019-12-31 $38,984
2019-09-30 $31,745
2019-06-30 $31,330
2019-03-31 $32,034
2018-12-31 $32,656
2018-09-30 $31,841
2018-06-30 $32,974
2018-03-31 $33,641
2017-12-31 $31,836
2017-09-30 $33,265
2017-06-30 $31,783
2017-03-31 $32,313
2016-12-31 $33,841
2016-09-30 $32,875
2016-06-30 $33,628
2016-03-31 $32,864
2015-12-31 $39,389
2015-09-30 $14,046
2015-06-30 $14,285
2015-03-31 $14,689
2014-12-31 $16,668
2014-09-30 $16,648
2014-06-30 $17,118
2014-03-31 $14,606
2013-12-31 $14,328
2013-09-30 $15,050
2013-06-30 $15,258
2013-03-31 $15,816
2012-12-31 $15,515
2012-09-30 $15,243
2012-06-30 $15,854
2012-03-31
2011-12-31 $17,565
2011-09-30
2011-06-30 $18,397
2011-03-31
2010-12-31
2010-09-30 $17,952
2010-06-30
2010-03-31
2009-12-31
2009-09-30
2009-06-30
2009-03-31
Sector Industry Market Cap Revenue
Medical MED-DRUGS $21.306B $22.719B
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
Stock Name Country Market Cap PE Ratio
New York Community Bancorp (FLG) United States $4.269B 0.00
Acasti Pharma (GRCE) Canada $0.033B 0.00